Plant Comparison
Saffron vs Panax Ginseng
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Saffron and Panax Ginseng: they share 7 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cognitive function, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Saffron | Panax Ginseng | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Blood sugar / diabetes support | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Cognitive function | 1/10 | 9/10 | Stronger for Panax Ginseng |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Memory | 1/10 | 8/10 | Stronger for Panax Ginseng |
| Metabolic support | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Skin irritation | 1/10 | 5/10 | Stronger for Panax Ginseng |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.
The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.
The main bitter-tasting glycoside of the stigma, a precursor of safranal.
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.
Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
External Ids
Botanical Description
Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Habitat
Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Harvesting
The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Traditional Uses
Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Preparations
Stigma extract standardised to safranal/crocin content, taken as capsules; the form used in most clinical mood and metabolic studies.
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
Dosage
Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
Pairings
Not documented
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
References & Sources
- Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
https://doi.org/10.1093/nutrit/nuae076 - Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
https://doi.org/10.1002/hup.2434 - Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
https://doi.org/10.1016/j.jep.2022.115719 - Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
https://doi.org/10.3736/jintegrmed2013056 - Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
https://doi.org/10.1016/j.ctim.2017.06.001 - Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
https://doi.org/10.1089/cap.2018.0146 - Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
https://doi.org/10.1055/s-0034-1375681 - Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.6b04398 - Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
https://doi.org/10.1002/ptr.5622 - Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2014.10.009 - Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2018.03.041 - El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
https://doi.org/10.3390/nu14030597 - Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
https://doi.org/10.3390/molecules26051237 - Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L - Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
https://scholar.google.com/scholar?q=Avicenna - Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
https://scholar.google.com/scholar?q=Crocus%20sativus%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
https://doi.org/10.1016/j.jad.2014.11.035 - Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
https://doi.org/10.1055/a-0660-9565 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
https://doi.org/10.3389/fnut.2024.1349006 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ - Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
https://bygl.osu.edu/node/1458
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.